Israel Englander Novo Cure LTD Put Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$11.83 - $24.05 $7,098 - $14,430	600 Added 5.88%	10,800 $185,000
Q1 2024 May 15, 2024	SELL	$12.42 - $17.29 $114,264 - $159,068	-9,200 Reduced 47.42%	10,200 $159,000
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $127,995 - $181,470	11,500 Added 145.57%	19,400 $289,000
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $318,291 - $651,829	7,900 New	7,900 $327,000
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $9.01 Million - $12 Million	140,900 New	140,900 $10.3 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.07B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.